ArticleLifetime data analysis2026
Gradient boosting-based discrete failure time model for selecting time-varying effects and interactions.
Article in Lifetime data analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Analyzing survival data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program offers invaluable insight to guide cancer management. In these data the event times are recorded in units of months. In such datasets, it can be important to consider the selection of covariates, distinguish between time-varying and time-independent effects, and capture important interaction terms. However, variable selection is difficult to combine with the differentiation between time-varying and time-independent effects. Moreover, accurately selecting interaction terms is more challenging because of the hierarchy restriction that an interaction term should only enter a model if one or both associated main effects are also included. To resolve these issues, we develop a coordinate ascent-based gradient boosting procedure for discrete failure time models. This approach achieves variable selection in high-dimensional settings, differentiates between time-varying and time-independent variables, and selects important interaction terms under hierarchy restrictions. Traditional boosting stopping criteria are ad hoc, while preferable information-criteria-based rules necessitate defining degrees of freedom, a challenge in survival models. Our approach provides well-defined degrees of freedom and offers information-criteria-based stopping rules. Simulation studies show the proposed method achieves good selection performance. We apply the proposed method to SEER melanoma cancer data and select important risk factors, distinguish between time-varying and time-dependent effects and detect important two-way interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.